Sofosbuvir + Velpatasvir

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Sofosbuvir sofosbuvir
Velpatasvir velpatasvir

Brands with this exact combination

Brand	Dose	Manufacturer
EpclusaAUCAESEUGBHKSGTWUS	37.5 mg / 150 mg / 50 mg / 200 mg / 100 mg / 400 mg	Gilead Sciences Ireland Unlimited Company
Sofosbuvir 400mg / Velpatasvir 100mg tabletsAUESGB	400 mg / 100 mg / 200 mg / 50 mg / 150 mg / 37.5 mg	Gilead Sciences Ireland Unlimited Company
Velpatasvir and SofosbuvirUS	100 mg / 400 mg / 37.5 mg / 150 mg / 50 mg / 200 mg	Gilead Sciences, Inc.
Epclusa 200mg/50mg granules sachetsGB	200 mg / 50 mg / 150 mg / 37.5 mg	Gilead Sciences Ltd
Sofosbuvir 200mg / Velpatasvir 50mg granules sachets sugar freeGB	200 mg / 50 mg / 150 mg / 37.5 mg	Gilead Sciences Ltd
Sofosbuvir and VelpatasvirUS	100 mg / 400 mg	Asegua Therapeutics LLC
宜譜莎膜衣錠TW	—	香港商吉立亞醫藥有限公司台灣分公司
EPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottleAU	100 mg / 400 mg	Gilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

CA · EPCLUSA · 1 products · record
ES · EPCLUSA · 5 products · record
GB · EPCLUSA; Epclusa 200mg/50mg granules sachets · 5 products · record
US · EPCLUSA; Sofosbuvir and Velpatasvir · 5 products · record
AU · EPCLUSA · 1 products · record

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.